As part of our product development process, Qualia Creatine+ was put to the test to find out how users would respond. Here’s what we did, and what we discovered.
Qualia Studies
We conducted a pilot proteomics study to understand how real users responded to Qualia Stem Cell. Here’s what the research revealed.
As part of our product development process, Qualia Stem Cell was put to the test to find out how users would respond. Here’s what we did, and what we discovered.
We teamed up with Reputable Health to understand how real users responded to Qualia Night. Here are the results.
During the development of Qualia Joint Health, we put our newest health product to the test to find out how users would respond. Here are the results.
Explore the results of our second placebo-controlled clinical study for Qualia NAD+®.
During the development of Qualia Probiotic+ we put our newest product to the test to find out how users would respond. Here’s what we did, and how participants responded.
A double-blind, placebo-controlled clinical trial of Qualia Senolytic showed a statistically significant reduction in total scores of issues related to joint health and performance, which includes Joint Discomfort, Physical Function, and Joint Stiffness.
Read the exciting results of our double-blind, placebo-controlled clinical trial of Qualia NAD+.
During the development of the new and improved Qualia Mind® we put the new version of the product to the test to find out how users would respond. Here are the results.
During the development of Qualia Senolytic, Qualia put our newest healthy aging product to the test to find out how users would respond.
We share the results of our Qualia Magnesium+ beta study. Learn more!
A new study provides hope as cognitive decline improved after six months of personalized lifestyle interventions, including Qualia Mind.
In 2018, 71 volunteers tested Qualia Mitochondria+ for three weeks. Read the beta study results — what they took, what we tracked, and what they reported.
During the development of Qualia NAD+ we put our newest product to the test to find out how users would respond. Here’s what we did, and how participants responded.
The 36-Item Short Form Survey Instrument (SF-36) was developed at RAND as part of the Medical Outcomes Study. It is one of the most widely used tools to assess health status and health-related quality of life.
A small pilot study of Qualia Mitochondria+—originally branded as Qualia Life—was conducted on 9 individuals in November-December 2019 as part of a larger research project by Longevity Diagnostics Research.
A small pilot study of Qualia Mitochondria+—originally branded as Qualia Life—was conducted during the winter months of 2019-20. Functional testing was done using the AgeMeter® device and software.
